Over the last five years the financial performance of pharmacy has been subject to the following. Flat script growth; Loss of retail sales; Flat to declining retail margin; Loss of customers; A period of rising overheads, namely rent and wages.
With Markets recently focusing on the expectation of the US Quantitative Easing (QE) Program being tapered back, we have experienced a steepening of the yield curve, with longer term Swap rates rising significantly. Under a scenario where QE in the US is ended, longer term yields are likely to rise even further. By way of
The Fair Work Amendment Bill 2013 which was passed on 27 June 2013 has the effect of extending existing family friendly measures (‘the Amendments’) under Fair Work Act 2009 (‘the Act’). Pharmacy businesses should take particular note of these changes given that a significant proportion of a pharmacy’s employees will have or be expecting to
When purchasing a pharmacy, the buyer must consider several key aspects before making the final decision on the value that the business presents to them. Understanding these aspects and incorporating them into the purchase decision is fundamental to the long term viability of the pharmacy, especially in the current business environment.
Retail pharmacy has become a very competitive environment which is unduly exposed to high rentals and threatened by a continual ratcheting of the PBS. Where will prices of pharmacy head in the future? Certainly there are unknowns that are difficult to factor in, but with the volume of loan delinquencies it will take banks sometime
Selling your pharmacy, which is often your largest asset and also perhaps even your retirement purse, is a very large decision. When is the time right for such a move? There are many considerations that go into the decision to divest interest in a pharmacy. One of the key ingredients is the prevailing market conditions
The 2012/13 financial year has provided many challenges for pharmacy. It has also seemingly laid the road map for pharmacy moving forward. Challenges bring out the best in people and there has been many pharmacists working extremely hard to overcome the issues presented and continue to thrive in pharmacy as it remains a strong industry.
Recently, much has been made by the Australian Investment and Securities Commission (ASIC) and others of property spruikers enticing people to establish Self-Managed Superannuation Funds (SMSF) using the Limited Recourse Borrowing Arrangements (LRBA) inappropriately. The reality is that most investors follow a carefully-considered decision making process when it comes to superannuation investment.
On 25 January 2013 the Full Court of the Federal Court handed down its final decision in the case of ACE Insurance Ltd v Trifunovski [2013] FCAC 3 (‘ACE Insurance’). Upholding the first instance decision that five persons who had been classified as contractors were in fact employees at common law. ACE
Pharmacy Solutions Australia is well placed to comment on what is happening to the prices of pharmacies across the country. We have offices in Melbourne, Sydney and Brisbane and have operated as independent pharmacy business brokers for almost 20 years and transact between 25 and 35 pharmacies per annum. It is now the reality that